Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 14:6:100109.
doi: 10.1016/j.crphys.2023.100109. eCollection 2023.

Ca2+-regulated expression of high affinity methylaminoisobutryic acid transport in hippocampal neurons inhibited by riluzole and novel neuroprotective aminothiazoles

Affiliations

Ca2+-regulated expression of high affinity methylaminoisobutryic acid transport in hippocampal neurons inhibited by riluzole and novel neuroprotective aminothiazoles

Jeffrey D Erickson et al. Curr Res Physiol. .

Abstract

High affinity methylaminoisobutyric acid(MeAIB)/glutamine(Gln) transport activity regulated by neuronal firing occurs at the plasma membrane in mature rat hippocampal neuron-enriched cultures. Spontaneous Ca2+-regulated transport activity was similarly inhibited by riluzole, a benzothiazole anticonvulsant agent, and by novel naphthalenyl substituted aminothiazole derivatives such as SKA-378. Here, we report that spontaneous transport activity is stimulated by 4-aminopyridine (4-AP) and that phorbol-myristate acetate (PMA) increases high K+ stimulated transport activity that is inhibited by staurosporine. 4-AP-stimulated spontaneous and PMA-stimulated high K+-induced transport is not present at 7 days in vitro (DIV) and is maximal by DIV∼21. The relative affinity for MeAIB is similar for spontaneous and high K+-stimulated transport (Km ∼ 50 μM) suggesting that a single transporter is involved. While riluzole and SKA-378 inhibit spontaneous transport with equal potency (IC50 ∼ 1 μM), they exhibit decreased (∼3-5 X) potency for 4-AP-stimulated spontaneous transport. Interestingly, high K+-stimulated MeAIB transport displays lower and differential sensitivity to the two compounds. SKA-378-related halogenated derivatives of SKA-75 (SKA-219, SKA-377 and SKA-375) preferentially inhibit high K+-induced expression of MeAIB transport activity at the plasma membrane (IC50 < 25 μM), compared to SKA-75 and riluzole (IC50 > 100 μM). Ca2+-dependent spontaneous and high K+-stimulated MeAIB transport activity is blocked by ω-conotoxin MVIIC, ω-agatoxin IVA, ω-agatoxin TK (IC50 ∼ 500 nM) or cadmium ion (IC50 ∼ 20 μM) demonstrating that P/Q-type CaV channels that are required for activity-regulated presynaptic vesicular glutamate (Glu) release are also required for high-affinity MeAIB transport expression at the plasma membrane. We suggest that neural activity driven and Ca2+ dependent trafficking of the high affinity MeAIB transporter to the plasma membrane is a unique target to understand mechanisms of Glu/Gln recycling in synapses and acute neuroprotection against excitotoxic presynaptic Glu induced neural injury.

Keywords: Glutamate/glutamine cycle; Hippocampal neurons; Methylaminoisobutyric acid/glutamine transporter; Riluzole; SKA-378; Vesicle recycling.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests.

Figures

Fig. 1
Fig. 1
Spontaneous and high K + -stimulated expression of high affinity MeAIB transport activity at the plasma membrane in hippocampal neuronal cultures. A, 4-AP stimulates spontaneous (Spont) transport activity (200 μM, 15 min) and is dependent on neural network activity: TTX (1 μM), Ver (25 μM), N/A – NBQX (10 μM)/AP5 (50 μM), GABA (2 mM). Spontaneous expression of transport activity requires external Ca2+ ions (-Ca2+). Statistical values are compared to spontaneous transport activity alone. B, Developmental increase in 4-AP stimulated spontaneous transport is the same as spontaneous transport alone and occurs during the 2nd and 3rd post dissection (E19) weeks in vitro. Background values (-Ca2+) were subtracted. C, Pretreatment with PMA (50 nM, 10 min) stimulates expression of transport activity after high K+ exposure (60 mM, 5 min) that is selectively blocked by staurosporine (stauro, 200 nM). The inactive 4-alphaPMA does not stimulate transport. High K+-expression of transport activity also requires external Ca2+ ion (-Ca2+). Statistical values are compared to high K+-stimulated transport alone. D, Developmental increase for PMA stimulation of transport activity after high K+ exposure occurs is the same as high K+ stimulation alone and occurs during the 2nd and 3rd post dissection weeks in vitro. Background values (-Ca2+) were subtracted. A value of p < 0.05 is regarded as statistically significant (**p < 0.01, ****p < 0.0001).
Fig. 2
Fig. 2
Chemical structures of riluzole, SKA-75, SKA-378, SKA-219, SKA-377 and SKA-375.
Fig. 3
Fig. 3
Potency of riluzole, SKA-75 and halogenated derivatives of SKA-75 on spontaneous and high K+expression of MeAIB transport activity. A, Concentration response curves reveal that SKA-378 (green), SKA-219 (purple), SKA-377 (orange), and SKA-375 (black) similarly inhibit spontaneous high affinity MeAIB transport activity similar to riluzole (blue). The curve is shifted to the right for SKA-75 (red), yet the IC50 value is still in the low μM range. B, Concentration response curves for all compounds are shifted to the right in the presence of 4-AP (200 μM) with IC50 values 3-5X greater than for spontaneous transport alone. C, Concentration response curves for all compounds are further shifted to the right (5-50X) with PMA but now riluzole joins SKA-75 as least potent. D, Following high K+-exposure and stimulation with PMA, concentration response curves show that all halogenated SKA-75 derivatives are more potent than SKA-75 or riluzole. All IC50 values in A-D are compared to SKA-378. A value of p < 0.05 is regarded as statistically significant (****p < 0.0001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 4
Fig. 4
Non-competitive inhibition by SKA-378 of Ca2+-dependent high K+ stimulation of high affinity MeAIB transport activity. A, Michaelis-Menten kinetics of MeAIB uptake in the presence of SKA-378 (25 μM). Background was measured in the absence of Ca2+ ions at each MeAIB concentration and was subtracted. Representative kinetic experiment is shown and was repeated twice. B, Eadie-Hofstee scatchard analysis shows that the -slope (Km) is not affected by SKA-378 while the initial velocity (V, Vmax) of transport is reduced by ∼50% by SKA-378. C, Concentration response curves for inhibition of spontaneous and high K+ stimulated transport by P/Q calcium channel (CaV) antagonists ω-conotoxin MVIIC (MVIIC) and cadmium ions (Cd2+). MVIIC or Cd2+ were present only during the high K+-depolarization period to block expression of MeAIB transport activity to the plasma membrane. Background uptake was determined by omitting Ca2+ ion during spontaneous uptake or during the high K+-stimulation period and were subtracted. The potency of MVIIC to inhibit spontaneous vs. high K+-stimulated transport was not statistically different (p > 0.99). The potency of Cd2+ to inhibit spontaneous vs. high K+-stimulated transport was not statistically different (p = 0.27). Values are results from 3 independent neuronal cultures.
Fig. 5
Fig. 5
Model of the Glu/Gln cycle between neurons and astrocytes that could recycle Glu for neurotransmission indicates where the neural activity regulated MeAIB/Gln transport system we describe further here operates (blue) that supports the concept of a Ca2+-dependent pathway for cycling of this high affinity transporter under spontaneous and by high K+ stimulation in synaptic terminals for exocytotic release. Our data indicate that SKA-378 targets an unidentified site (X) to inhibit Ca2+-dependent exocytosis and recycling of MeAIB transport activity to the plasma membrane in hippocampal neurons >5X more potently than riluzole. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

References

    1. Albrecht J., Sonnewald U., Waagepetersen H.S., Schousboe A. Glutamine in the central nervous system: function and dysfunction. Front. Biosci. 2007;12:332–343. - PubMed
    1. Alvina K., Khodakhah K. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J. Neurosci. 2010;30:7258–7268. - PMC - PubMed
    1. Amara S.G., Fontana A.C. Excitatory amino acid transporters: keeping up with glutamate. Neurochem. Int. 2002;41:313–318. - PubMed
    1. Bae H.-J., Lee Y.-S., Kang D.-W., Gu J.-S., Yoon B.-W., Roh J.-K. Neuroprotective effect of low dose riluzole in gerbil model of transient global ischemia. Neurosci. Lett. 2000;294:29–32. - PubMed
    1. Boulland J.L., Qureshi T., Seal R.P., et al. Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J. Comp. Neurol. 2004;480:264–280. - PubMed